Awakn Life Sciences Drug Discovery Program Files Patent Application for a New Class of Entactogen-Like Molecules Feb 17, 2022
Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Exploring Psilocybin Treatments in Underserved Indications Jul 30, 2021
